Results 51 to 60 of about 96,811 (318)

3D Anodic Alumina Nanoarchitectures: A Decade of Progress from Foundational Science to Functional Metamaterials

Advanced Materials, EarlyView.
Ordered three‐dimensional anodic aluminum oxide (3D‐AAO) nanoarchitectures with longitudinal and transverse pores enable architecture‐driven metamaterials. The review maps fabrication advances, including hybrid pulse anodization, and shows how 3D‐AAO templates tailor properties across magnetism, energy, catalysis, and sensing.
Marisol Martín‐González
wiley   +1 more source

Efficacy and Safety of Drug-Eluting Stents in the Real World: 8-Year Follow-Up

Arquivos Brasileiros de Cardiologia, 2014
Background: Drug-eluting stents have been used in daily practice since 2002, with the clear advantages of reducing the risk of target vessel revascularization and an impressive reduction in restenosis rate by 50%-70%.
Denise Oliveira Pellegrini, Vitor Osório Gomes, Ricardo Lasevitch, Luis Smidt, Marco Aurélio Azeredo, Priscila Ledur, Rodrigo Bodanese, Leonardo Sinnott, Emílio Moriguchi, Paulo Caramori   +9 more
doaj   +1 more source

Meta-analysis of randomized trials on drug-eluting stents vs. bare-metal stents in patients with acute myocardial infarction [PDF]

, 2017
Aims To compare the efficacy and safety of drug-eluting stents vs. bare-metal stents in patients with acute ST-segment elevation myocardial infarction.
Di Lorenzo, Emilio, Dibra, Alban, Dirksen, Maurits T., Kaiser, Christoph, Kastrati, Adnan, Laarman, Gerrit J., Mehilli, Julinda, Menichelli, Maurizio, Percoco, Gianfranco, Pittl, Undine, Schömig, Albert, Seyfarth, Melchior, Spaulding, Christian, Suttorp, Maarten J., Syvänne, Mikko, Tierala, Ilkka, Valgimigli, Marco, Varenne, Olivier, Varricchio, Attilio, Violini, Roberto   +19 more
core  

Future of smart cardiovascular implants [PDF]

, 2018
Cardiovascular disease remains the leading cause of death in Western society. Recent technological advances have opened the opportunity of developing new and innovative smart stent devices that have advanced electrical properties that can improve ...
Bussooa, Anubhav, Mercer, John R., Neale, Steven   +2 more
core   +1 more source

Drug eluting coronary stents

BMJ, 2002
Percutaneous coronary revascularisation has revolutionised the treatment of ischaemic heart disease during the past two decades. Despite technical refinements, however, long term results after using standard techniques remain limited by the phenomenon of restenosis—a process whereby elastic recoil and neointimal hyperplasia occur at the site of ...
N P, Jenkins, B D, Prendergast, M, Thomas   +2 more
openaire   +3 more sources

Ultrafine Molybdenum Wire Braided Neurointerventional Implants: Bridging Biodegradability and Neurovascular Safety for Stroke Treatment

Advanced Science, EarlyView.
Molybdenum (Mo), with its unique strength, uniform corrosion, and radiopacity, enables innovative biodegradable implants for transformative stroke therapy. Abstract Neurovascular implants for stroke intervention face a critical dilemma: permanent devices (e.g., nitinol stents, platinum coils) often trigger chronic inflammation and recurrence, whereas ...
Yunong Shen, Yiming Huang, Yang Zhang, Chunhao Yu, Hanqi Liu, Dong Bian, Di Wu, Wu Wang, Xunming Ji, Yufeng Zheng, Miaowen Jiang, Ming Li   +11 more
wiley   +1 more source

Very Late Pathological Responses to Cobalt–Chromium Everolimus‐Eluting, Stainless Steel Sirolimus‐Eluting, and Cobalt–Chromium Bare Metal Stents in Humans

Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease, 2017
BackgroundThe “very late” clinical outcomes for durable polymer drug‐eluting stents and bare metal stents (BMSs) have been shown to be dissimilar in clinical studies.
Hiroyoshi Mori, Dheeraj R. Atmakuri, Sho Torii, Ryan Braumann, Samantha Smith, Hiroyuki Jinnouchi, Anuj Gupta, Emanuel Harari, Melsi Shkullaku, Robert Kutys, David Fowler, Maria Romero, Renu Virmani, Aloke V. Finn   +13 more
doaj   +1 more source

Relationship Between Intravascular Ultrasound Guidance and Clinical Outcomes After Drug-Eluting Stents: Two-Year Follow-Up of the ADAPT-DES Study

Circulation. Cardiovascular Interventions, 2018
Background: In the large-scale ADAPT-DES study (Assessment of Dual Antiplatelet Therapy With Drug-Eluting Stents), drug-eluting stent implantation with intravascular ultrasound (IVUS) guidance was associated with a reduction in 1-year rates of stent ...
A. Maehara, G. Mintz, B. Witzenbichler, G. Weisz, F. Neumann, M. Rinaldi, D. Metzger, T. Henry, D. Cox, Peter L Duffy, B. Brodie, T. Stuckey, E. Mazzaferri, T. McAndrew, P. Généreux, R. Mehran, A. Kirtane, G. Stone   +17 more
semanticscholar   +1 more source

Implantable Drug Delivery Systems for Skeletal Muscles and Eyes

Advanced NanoBiomed Research, EarlyView.
This review highlights the different types of recent implantable drug delivery systems (IDDS) fabricated for a use with skeletal muscles, and with eyes. It presents the developments already made and the current research directions, showing the evolution of IDDS and their great diversity.
Serge Ostrovidov, Murugan Ramalingam, Hongkai Wu, Toshinori Fujie, Yukinari Nakamura, Takeshi Hori, Yuji Nashimoto, Xuetao Shi, Hirokazu Kaji   +8 more
wiley   +1 more source

Drug-eluting stents: long-term safety

Терапевтический архив, 2009
The review concerns the problem of late thromboses of drug-eluting stents and their influence on late prognosis of the patients; presents long-term results of the trial of sirolimus-eluting stents implanted to patients with coronary heart disease ...
Yu A Karpov, A N Samko, V V Buza, Yu A Karpov, A N Samko, V V Buza   +5 more
doaj